The Hidden AI Risks Pharma Teams Face Every Day
Pharmaceutical companies are racing to adopt AI for regulatory document work, and most are doing it without the controls the industry requires. Staff connect directly to ChatGPT, Claude or another AI service, and every unsupervised exchange involving confidential drug development information becomes a potential audit finding, a data breach, or a delayed submission.
The problem is not AI itself — it is the absence of governance. When regulatory teams use AI tools with no central oversight, there is no audit trail, no protection against confidential information leaving the organisation, and no consistency in what comes back. A single AI-generated error in an FDA submission can cost millions in delay. This is why DnXT built a controlled route for all AI use, designed for regulatory compliance from the start.
Most AI implementations fail pharmaceutical companies because they prioritise speed over compliance. In regulated industries, compliance is not optional — it is the foundation of a successful approval.
Who This Is For
- VP Regulatory Affairs — needs the speed AI offers without compromising submission integrity or audit readiness
- Regulatory Publishing Managers — drowning in manual document creation while under pressure to adopt AI safely
- Quality Assurance Directors — must ensure every AI interaction meets FDA and EMA validation requirements with a complete audit trail
- CRO Project Managers — extending AI across several sponsors while keeping each one’s information strictly separate
- IT Directors in Life Sciences — balancing demand for AI against security, compliance and cost control
How It Works
- One controlled route. Every AI request from every DnXT application goes through a single controlled point. Nobody connects directly to an outside AI service.
- Choice of AI provider. Requests are directed to Azure OpenAI, Anthropic Claude, OpenAI or Google — chosen on cost, availability, and what each customer has agreed to use.
- Screening before anything leaves. Content is checked for personal information (social security numbers, card numbers, email addresses, phone numbers), for attempts to manipulate the AI into ignoring its instructions, and for anything your organisation has chosen to block.
- Credentials held securely and separately. Each customer’s AI provider credentials are encrypted and stored separately, so no two customers can ever reach each other’s.
- Spending limits. Limits per minute, per hour and per day prevent runaway costs, with alerts to administrators as budgets are approached.
- A complete record. Every AI interaction is recorded — who asked, when, what was sent, what came back — to satisfy FDA 21 CFR Part 11 requirements.
- Checking what comes back. Responses are screened at a minimal, standard or strict level before reaching the user, so what is returned is appropriate for regulatory use.
Key Benefits
- A complete regulatory audit trail. Every AI interaction is recorded with full traceability, meeting FDA validation expectations for computer systems used in regulated work. Records include who was signed in, when, and a check that the record has not been altered.
- Security that fits the industry. Screening prevents confidential or personal information leaving the organisation by accident, and blocks attempts to manipulate the AI into behaving differently. Everything returned is screened before anyone sees it.
- Cost control per customer. Budget limits and usage reporting prevent overspending and give finance something to plan against. Directing work to the most cost-effective provider keeps the bill down.
- No lock-in to one AI supplier. Several providers are supported. If one has an outage or changes its pricing, work moves to another without interrupting your team.
- Scale. The service handles thousands of simultaneous requests while keeping response times under a second.
- Nothing to change in how people work. It fits into existing DnXT Publisher Suite workflows, so governance is added behind the scenes without asking anyone to work differently.
Real-World Impact
| Challenge | Before | After |
|---|---|---|
| Audit compliance | No record of AI use, documented by hand | Complete automatic records, 21 CFR Part 11 compliant |
| Security risk | Direct connections to AI services, confidential data exposed | Nothing confidential leaves; controls applied centrally |
| Cost management | Uncontrolled spending, surprise bills | 40–60% lower cost through smart routing and reuse |
| Keeping customers separate | Shared credentials, risk of crossover | Complete separation, credentials encrypted per customer |
| Supplier dependency | Tied to a single AI vendor | Several providers, switching automatically if one fails |
One mid-sized pharmaceutical company reduced their document review cycle from three weeks to five days while maintaining full audit compliance. Their AI-assisted eCTD submissions showed 85% fewer formatting errors, with complete traceability for FDA inspections.
Why This Matters for Regulatory Teams
The FDA’s Computer Software Assurance guidance emphasises validated systems in pharmaceutical operations. AI tools used for regulatory submissions must show the same rigour as any other computer system in the validation chain — documented testing, change control, audit trails and security controls.
EMA guidelines on computerised systems require any AI handling regulatory data to have appropriate access controls, data integrity measures and complete audit trails. DnXT addresses these by design, not as an afterthought.
As AI adoption accelerates in pharmaceutical R&D, regulatory teams need a platform that balances innovation with compliance — so that AI becomes a competitive advantage rather than a regulatory liability.
Get Started
Ready to bring AI use under proper governance? DnXT fits into your existing document workflows while providing the security, compliance and cost controls regulated industries demand.
Contact our regulatory technology specialists to arrange a demonstration and see how this can shorten your submission timelines while keeping you inspection-ready. Visit https://www.dnxtsolutions.com/contacts/ to get started.
Related Resources
About DnXT Solutions
DnXT Solutions provides cloud-native eCTD publishing, review, and regulatory compliance tools for life sciences companies. With 340+ submissions published and 20+ customers, DnXT is the regulatory platform purpose-built for speed and accuracy.
